Alcohol dehydrogenase-specific T-cell responses are associated with alcohol consumption in patients with alcohol-related cirrhosis

Hepatology

Volumn 58, Issue 1, 2013, Pages 314-324

  Lin, Fang ^a,b   Taylor, Nicholas J ^a   Su, Haibin ^a,b   Huang, Xiaohong ^a   Hussain, Munther J ^a   Abeles, Robin Daniel ^a   Blackmore, Laura ^a   Zhou, Yunyun ^a   Ikbal, Mohammad Mashfick ^a   Heaton, Nigel ^a   Jassem, Wayel ^a   Shawcross, Debbie L ^a   Vergani, Diego ^a   Ma, Yun ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b BEIJING 302 HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL DEHYDROGENASE; EPITOPE; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 4; VASOPRESSIN;

ADULT; AGED; ALCOHOL ABSTINENCE; ALCOHOL CONSUMPTION; ALCOHOL LIVER CIRRHOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CELL CULTURE; CELL PROLIFERATION; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONSUMER; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DISEASE SEVERITY; DRINKING; FEMALE; HUMAN; HUMAN CELL; LIVER CELL; MALE; MONONUCLEAR CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE; TH1 CELL; TH17 CELL;

ADULT; AGED; ALCOHOL DEHYDROGENASE; ALCOHOL DRINKING; FEMALE; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-17; INTERLEUKIN-4; LEUKOCYTES, MONONUCLEAR; LIVER CIRRHOSIS, ALCOHOLIC; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; T-LYMPHOCYTES; TEMPERANCE; TH1 CELLS;

EID: 84879603417     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.26334     Document Type: Article

References (31)

1. Seth D, Haber PS, Syn WK, Diehl AM, Day CP. Pathogenesis of alcohol-induced liver disease: classical concepts and recent advances. J Gastroenterol Hepatol 2011; 26: 1089-1105.
2. Li TK. Quantifying the risk for alcohol-use and alcohol-attributable health disorders: present findings and future research needs. J Gastroenterol Hepatol 2008; 23( suppl 1): S2-S8.
3. Marcos M, Pastor I, Gonzalez-Sarmiento R, Laso FJ. Common polymorphisms in interleukin genes (IL4, IL6, IL8 and IL12) are not associated with alcoholic liver disease or alcoholism in Spanish men. Cytokine 2009; 45: 158-161.
4. Vidal F, Lorenzo A, Auguet T, Olona M, Broch M, Gutierrez C, et al. Genetic polymorphisms of ADH2, ADH3, CYP4502E1 Dra-I and Pst-I, and ALDH2 in Spanish men: lack of association with alcoholism and alcoholic liver disease. J Hepatol 2004; 41: 744-750.
5. Stickel F, Osterreicher CH. The role of genetic polymorphisms in alcoholic liver disease. Alcohol Alcohol 2006; 41: 209-224.
6. Guo W, Lanzi G, Luobu O, Ma X, Zhen P, Ji Y, et al. An epidemiological survey of alcohol use disorders in a Tibetan population. Psychiatry Res 2008; 159: 56-66.
7. Gao B, Seki E, Brenner DA, Friedman S, Cohen JI, Nagy L, et al. Innate immunity in alcoholic liver disease. Am J Physiol Gastrointest Liver Physiol 2011; 300: G516-G525.
8. Laso FJ, Iglesias-Osma C, Ciudad J, Lopez A, Pastor I, Orfao A. Chronic alcoholism is associated with an imbalanced production of Th-1/Th-2 cytokines by peripheral blood T cells. Alcohol Clin Exp Res 1999; 23: 1306-1311.
9. Albano E. Role of adaptive immunity in alcoholic liver disease. Int J Hepatol 2012; 2012: 893026.
10. Ma Y, Gaken J, McFarlane BM, Foss Y, Farzaneh F, McFarlane IG, et al. Alcohol dehydrogenase: a target of humoral autoimmune response in liver disease. Gastroenterology 1997; 112: 483-492.
11. Perperas A, Tsantoulas D, Portmann B, Eddleston AL, Williams R. Autoimmunity to a liver membrane lipoprotein and liver damage in alcoholic liver disease. Gut 1981; 22: 149-152.
12. Chedid A, Chadalawada KR, Morgan TR, Moritz TE, Mendenhall CL, Hammond JB, et al. Phospholipid antibodies in alcoholic liver disease. HEPATOLOGY 1994; 20: 1465-1471.
13. Lemmers A, Moreno C, Gustot T, Marechal R, Degre D, Demetter P, et al. The interleukin-17 pathway is involved in human alcoholic liver disease. HEPATOLOGY 2009; 49: 646-657.
14. Jornvall H, Hoog JO, von Bahr-Lindstrom H, Vallee BL. Mammalian alcohol dehydrogenases of separate classes: intermediates between different enzymes and intraclass isozymes. Proc Natl Acad Sci U S A 1987; 84: 2580-2584.
15. Ma Y, Meregalli M, Hodges S, Davies N, Bogdanos DP, Fargion S, et al. Alcohol dehydrogenase: an autoantibody target in patients with alcoholic liver disease. Int J Immunopathol Pharmacol 2005; 18: 173-182.
16. Ma Y, Bogdanos DP, Hussain MJ, Underhill J, Bansal S, Longhi MS, et al. Polyclonal T-cell responses to cytochrome P450IID6 are associated with disease activity in autoimmune hepatitis type 2. Gastroenterology 2006; 130: 868-882.
17. Vergani D, Choudhuri K, Bogdanos DP, Mieli-Vergani G. Pathogenesis of autoimmune hepatitis. Clin Liver Dis 2002; 6: 727-737.
18. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. HEPATOLOGY 2001; 33: 464-470.
19. Surh CD, Sprent J. Homeostasis of naive and memory T cells. Immunity 2008; 29: 848-862.
20. Hussain MJ, Maher J, Warnock T, Vats A, Peakman M, Vergani D. Cytokine overproduction in healthy first degree relatives of patients with IDDM. Diabetologia 1998; 41: 343-349.
21. Longhi MS, Ma Y, Mitry RR, Bogdanos DP, Heneghan M, Cheeseman P, et al. Effect of CD4+ CD25+ regulatory T-cells on CD8 T-cell function in patients with autoimmune hepatitis. J Autoimmun 2005; 25: 63-71.
22. Leifeld L, Cheng S, Ramakers J, Dumoulin FL, Trautwein C, Sauerbruch T, et al. Imbalanced intrahepatic expression of interleukin 12, interferon gamma, and interleukin 10 in fulminant hepatitis B. HEPATOLOGY 2002; 36: 1001-1008.
23. MacLeod MK, McKee A, Crawford F, White J, Kappler J, Marrack P. CD4 memory T cells divide poorly in response to antigen because of their cytokine profile. Proc Natl Acad Sci U S A 2008; 105: 14521-14526.
24. Rupa P, Mine Y. Oral immunotherapy with immunodominant T-cell epitope peptides alleviates allergic reactions in a Balb/c mouse model of egg allergy. Allergy 2012; 67: 74-82.
25. Kawaratani H, Tsujimoto T, Kitazawa T, Yoshiji H, Uemura M, Fukui H. Therapeutic effects of cytokine modulator Y-40138 in the rat alcoholic liver disease model. J Gastroenterol Hepatol 2011; 26: 775-783.
26. Crews FT, Bechara R, Brown LA, Guidot DM, Mandrekar P, Oak S, et al. Cytokines and alcohol. Alcohol Clin Exp Res 2006; 30: 720-730.
27. Wynn TA. Fibrotic disease and the T(H)1/T(H)2 paradigm. Nat Rev Immunol 2004; 4: 583-594.
28. King C, Mueller Hoenger R, Malo Cleary M, Murali-Krishna K, Ahmed R, King E, et al. Interleukin-4 acts at the locus of the antigen-presenting dendritic cell to counter-regulate cytotoxic CD8+ T-cell responses. Nat Med 2001; 7: 206-214.
29. Mandayam S, Jamal MM, Morgan TR. Epidemiology of alcoholic liver disease. Semin Liver Dis 2004; 24: 217-232.
30. Mathurin P, Mendenhall CL, Carithers RL Jr, Ramond MJ, Maddrey WC, Garstide P, et al. Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH. J Hepatol 2002; 36: 480-487.
31. Maddrey WC, Boitnott JK, Bedine MS, Weber FL Jr, Mezey E, White RI Jr. Corticosteroid therapy of alcoholic hepatitis. Gastroenterology 1978; 75: 193-199.